Dermira, Inc. DERM Balance Sheet

Dermira, inc. (DERM)

Balance Sheet / TTM

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Dec'13
Assets
Current assets:
Cash and cash equivalents
74,903	103,155	201,693	104,976	144,976	176,307	288,568	295,923	393,631	418,308	201,917	41,793	55,656	210,981	92,371	107,242	120,276	32,713	52,144	55,358	50,845	22,144
Short-term investments
283,231	222,014	186,137	208,064	233,923	260,620	207,225	255,070	269,252	272,453	212,710	210,149	186,266	86,880	96,932	107,451	94,740	87,693	70,332	41,793	-	-
Trade and other receivables, net
11,057	59,795	8,450	5,724	2,114	56	57	52	-	-	10,700	21,400	25,000	-	-	-	7,300	-	-	7,300	-	-
Inventory
23,508	17,644	13,355	8,370	2,919	102	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
19,820	25,862	33,373	8,275	9,252	10,233	6,237	5,569	7,768	7,949	8,012	10,649	6,586	5,464	3,893	2,540	1,872	2,123	2,014	1,012	569	344
Total current assets
412,519	428,470	443,008	335,409	393,184	447,318	502,087	556,614	670,651	698,710	433,339	283,991	273,508	303,325	193,196	217,233	224,188	122,529	124,490	105,463	51,414	22,488
Property and equipment, net
828	864	964	1,180	1,300	1,395	1,500	1,433	929	1,003	1,092	1,127	413	435	460	386	284	223	177	192	79	61
Long-term investments
2,029	1,997	-	2,962	10,829	35,567	-	-	-	5,186	18,430	24,551	34,722	-	-	1,019	17,441	23,399	35,668	66,483	-	-
Operating lease right-of-use asset
12,290	13,144	13,978	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets
879	903	927	952	976	1,000	-	1,126	1,126	1,126	1,126	1,126	1,126	1,126	1,126	1,126	3,520	3,520	3,520	3,520	3,520	3,520
Goodwill
771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771	771
Restricted cash
655	804	803	802	801	801	801	800	-	-	-	-	-	-	-	-	-	-	-	-	500	-
Other assets
6,270	313	1,124	2,245	2,061	593	698	50	972	992	1,013	1,035	961	969	1,249	1,397	998	1,002	985	1,792	3,332	31
Total assets
436,241	447,266	461,575	344,321	409,922	487,445	505,857	560,794	674,449	707,788	455,771	312,601	311,501	306,626	196,802	221,932	247,202	151,444	165,611	178,221	59,616	26,871
Liabilities and stockholders’ equity (deficit)
Current liabilities:
Accounts payable
11,247	11,549	6,081	15,948	13,465	12,345	10,580	15,094	9,741	8,476	5,406	13,500	6,226	8,796	12,540	9,230	6,769	5,648	6,783	5,563	3,165	2,322
Accrued liabilities
23,026	20,029	21,826	22,608	31,084	24,561	24,616	25,115	26,738	15,862	11,640	17,227	19,175	16,591	14,101	16,666	12,338	7,278	5,213	6,327	4,486	1,999
Lease liability, current
4,255	4,220	4,187	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Refund liability
-	-	-	-	-	2,820	10,000	10,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued payments related to acquired in-process research and development
-	-	-	-	29,727	53,921	51,802	50,161	102,517	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, current
20,110	15,075	30,000	-	-	-	80	4,988	4,265	4,265	4,265	4,265	3,298	-	-	-	-	-	-	-	-	-
Convertible preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	139	61
Bank term loan, current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200	-	-	-	-	133
Total current liabilities
58,638	50,873	62,094	38,556	74,276	93,647	97,078	105,358	143,261	28,603	21,311	34,992	28,699	25,387	26,641	25,896	19,307	12,926	11,996	11,890	7,790	4,515
Long-term liabilities:
Term loan
71,808	32,731	32,690	32,566	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Convertible notes, net
282,607	282,145	281,684	281,223	280,764	280,305	279,847	279,389	278,938	278,468	-	-	-	-	-	-	-	-	-	-	-	-
Lease liability, non-current
8,708	9,621	10,513	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, non-current
-	6,340	-	-	-	-	-	25,286	26,352	27,418	28,484	29,550	31,583	10,000	10,000	10,000	10,000	10,000	10,000	10,000	10,000	10,000
Bank term loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,748	1,944	1,940	1,936	1,937	1,786
Deferred tax liability
-	-	-	-	-	-	-	194	194	194	194	194	194	194	194	194	816	816	816	816	785	785
Accrued payment related to acquired in-process research and development, non-current
-	-	-	-	-	-	-	-	26,290	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
-	-	-	1,015	1,035	1,046	1,059	918	687	696	686	495	156	123	101	367	575	557	-	-	-	-
Total liabilities
421,761	381,710	386,981	353,360	356,075	374,998	377,984	411,145	475,722	335,379	50,675	65,231	60,632	35,704	36,936	36,457	32,446	26,243	24,752	24,642	20,512	17,086
Commitments and contingencies (Note 7)
-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	-
Convertible preferred stock, $0.001 par value per share; no shares and 10,107,111 shares authorized as of December 31, 2014 and 2013, respectively; no shares and 9,540,158 shares issued and outstanding as of December 31, 2014 and 2013, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	113,414	59,588
Stockholders’ equity (deficit):
Preferred stock, $0.001 par value per share; 10,000 shares authorized as of December 31, 2018; no shares issued and outstanding as of December 31, 2018 or 2017
-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	-	0
Common stock
55	54	54	42	42	42	42	42	42	42	42	36	36	35	30	30	30	25	25	25	1	1
Additional paid-in capital
899,750	893,221	884,379	736,095	727,184	719,259	710,926	703,215	696,152	690,785	684,870	497,718	493,681	488,083	349,272	346,590	344,645	239,118	237,550	236,414	1,611	970
Accumulated other comprehensive income (loss)
128	113	31	-138	-151	-170	-343	-215	-86	-211	-175	-252	-99	43	48	-97	-22	-99	-32	-211	-	-
Accumulated deficit
-885,453	-827,832	-809,870	-745,038	-673,228	-606,684	-582,752	-553,393	-497,381	-318,207	-279,641	-250,132	-242,749	-217,239	-189,484	-161,048	-129,897	-113,843	-96,684	-82,649	-75,922	-50,774
Total stockholders’ equity (deficit)
14,480	65,556	74,594	-9,039	53,847	112,447	127,873	149,649	198,727	372,409	405,096	247,370	250,869	270,922	159,866	185,475	214,756	125,201	140,859	153,579	-74,310	-49,803
Total liabilities and stockholders’ equity (deficit)
436,241	447,266	461,575	344,321	409,922	487,445	505,857	560,794	674,449	707,788	455,771	312,601	311,501	306,626	196,802	221,932	247,202	151,444	165,611	178,221	59,616	26,871